ERBB2 and ductal breast carcinoma in situ: The second experimental condition relied on activation of ectopic avian erythroblastosis oncogene B (ErbB2), a proto-oncogene up-regulated in 25% of metastatic breast cancers and 20–80% of Ductal Carcinoma in Situ (DCIS)22, 30.